{"url_path":"/sec/pths/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1919246/0001919246-26-000071-index.html","accession_number":"0001919246-26-000071","cik":"0001919246","ticker":"PTHS","issuer_name":"Pelthos Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1919246/0001919246-26-000071-index.html","primary_entity_key":"0001919246","primary_entity_name":"Pelthos Therapeutics Inc."},"word_count":77,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits\n\n(d)Exhibits:\n\nExhibit No.Description\n\n99.1\n[Press Release, dated May 14, 2026](pths-pressreleasex20250514.htm)\n\n99.2\n[Company Presentation](investmentdeck_202605x99.htm)\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDate: May 14, 2026Pelthos Therapeutics Inc.\n\nBy:/s/ John M. Gay\n\nName:John M. Gay\n\nTitle:Chief Financial Officer"}